STAB2 Antibody (Stabilin-2 Precursor) Market - Global Outlook and Forecast 2022-2028

January 2022 | 71 pages | ID: S88F1A4A835DEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of STAB2 Antibody (Stabilin-2 Precursor) in Global, including the following market information:

Global STAB2 Antibody (Stabilin-2 Precursor) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global STAB2 Antibody (Stabilin-2 Precursor) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibody Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of STAB2 Antibody (Stabilin-2 Precursor) include Thermo Fisher Scientific, Merck (Sigma-Aldrich), Abcam, R&D Systems, Novus Biologicals, Bioss Antibodies, Boster Bio and Atlas Antibodies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the STAB2 Antibody (Stabilin-2 Precursor) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global STAB2 Antibody (Stabilin-2 Precursor) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global STAB2 Antibody (Stabilin-2 Precursor) Market Segment Percentages, by Type, 2021 (%)

• Monoclonal Antibody
• Polyclonal Antibody

Global STAB2 Antibody (Stabilin-2 Precursor) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global STAB2 Antibody (Stabilin-2 Precursor) Market Segment Percentages, by Application, 2021 (%)

• Human
• Animal

Global STAB2 Antibody (Stabilin-2 Precursor) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global STAB2 Antibody (Stabilin-2 Precursor) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies STAB2 Antibody (Stabilin-2 Precursor) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies STAB2 Antibody (Stabilin-2 Precursor) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• Merck (Sigma-Aldrich)
• Abcam
• R&D Systems
• Novus Biologicals
• Bioss Antibodies
• Boster Bio
• Atlas Antibodies

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 STAB2 Antibody (Stabilin-2 Precursor) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global STAB2 Antibody (Stabilin-2 Precursor) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL STAB2 ANTIBODY (STABILIN-2 PRECURSOR) OVERALL MARKET SIZE

2.1 Global STAB2 Antibody (Stabilin-2 Precursor) Market Size: 2021 VS 2028
2.2 Global STAB2 Antibody (Stabilin-2 Precursor) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top STAB2 Antibody (Stabilin-2 Precursor) Players in Global Market
3.2 Top Global STAB2 Antibody (Stabilin-2 Precursor) Companies Ranked by Revenue
3.3 Global STAB2 Antibody (Stabilin-2 Precursor) Revenue by Companies
3.4 Top 3 and Top 5 STAB2 Antibody (Stabilin-2 Precursor) Companies in Global Market, by Revenue in 2021
3.5 Global Companies STAB2 Antibody (Stabilin-2 Precursor) Product Type
3.6 Tier 1, Tier 2 and Tier 3 STAB2 Antibody (Stabilin-2 Precursor) Players in Global Market
  3.6.1 List of Global Tier 1 STAB2 Antibody (Stabilin-2 Precursor) Companies
  3.6.2 List of Global Tier 2 and Tier 3 STAB2 Antibody (Stabilin-2 Precursor) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global STAB2 Antibody (Stabilin-2 Precursor) Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal Antibody
  4.1.3 Polyclonal Antibody
4.2 By Type - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue & Forecasts
  4.2.1 By Type - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2017-2022
  4.2.2 By Type - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2023-2028
  4.2.3 By Type - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2021 & 2028
  5.1.2 Human
  5.1.3 Animal
5.2 By Application - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue & Forecasts
  5.2.1 By Application - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2017-2022
  5.2.2 By Application - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2023-2028
  5.2.3 By Application - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2021 & 2028
6.2 By Region - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue & Forecasts
  6.2.1 By Region - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2017-2022
  6.2.2 By Region - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2023-2028
  6.2.3 By Region - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2017-2028
  6.3.2 US STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.3.3 Canada STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.3.4 Mexico STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2017-2028
  6.4.2 Germany STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.4.3 France STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.4.4 U.K. STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.4.5 Italy STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.4.6 Russia STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.4.7 Nordic Countries STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.4.8 Benelux STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2017-2028
  6.5.2 China STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.5.3 Japan STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.5.4 South Korea STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.5.5 Southeast Asia STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.5.6 India STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2017-2028
  6.6.2 Brazil STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.6.3 Argentina STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2017-2028
  6.7.2 Turkey STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.7.3 Israel STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.7.4 Saudi Arabia STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028
  6.7.5 UAE STAB2 Antibody (Stabilin-2 Precursor) Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific STAB2 Antibody (Stabilin-2 Precursor) Major Product Offerings
  7.1.4 Thermo Fisher Scientific STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 Merck (Sigma-Aldrich)
  7.2.1 Merck (Sigma-Aldrich) Corporate Summary
  7.2.2 Merck (Sigma-Aldrich) Business Overview
  7.2.3 Merck (Sigma-Aldrich) STAB2 Antibody (Stabilin-2 Precursor) Major Product Offerings
  7.2.4 Merck (Sigma-Aldrich) STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global Market (2017-2022)
  7.2.5 Merck (Sigma-Aldrich) Key News
7.3 Abcam
  7.3.1 Abcam Corporate Summary
  7.3.2 Abcam Business Overview
  7.3.3 Abcam STAB2 Antibody (Stabilin-2 Precursor) Major Product Offerings
  7.3.4 Abcam STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global Market (2017-2022)
  7.3.5 Abcam Key News
7.4 R&D Systems
  7.4.1 R&D Systems Corporate Summary
  7.4.2 R&D Systems Business Overview
  7.4.3 R&D Systems STAB2 Antibody (Stabilin-2 Precursor) Major Product Offerings
  7.4.4 R&D Systems STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global Market (2017-2022)
  7.4.5 R&D Systems Key News
7.5 Novus Biologicals
  7.5.1 Novus Biologicals Corporate Summary
  7.5.2 Novus Biologicals Business Overview
  7.5.3 Novus Biologicals STAB2 Antibody (Stabilin-2 Precursor) Major Product Offerings
  7.5.4 Novus Biologicals STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global Market (2017-2022)
  7.5.5 Novus Biologicals Key News
7.6 Bioss Antibodies
  7.6.1 Bioss Antibodies Corporate Summary
  7.6.2 Bioss Antibodies Business Overview
  7.6.3 Bioss Antibodies STAB2 Antibody (Stabilin-2 Precursor) Major Product Offerings
  7.6.4 Bioss Antibodies STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global Market (2017-2022)
  7.6.5 Bioss Antibodies Key News
7.7 Boster Bio
  7.7.1 Boster Bio Corporate Summary
  7.7.2 Boster Bio Business Overview
  7.7.3 Boster Bio STAB2 Antibody (Stabilin-2 Precursor) Major Product Offerings
  7.7.4 Boster Bio STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global Market (2017-2022)
  7.7.5 Boster Bio Key News
7.8 Atlas Antibodies
  7.8.1 Atlas Antibodies Corporate Summary
  7.8.2 Atlas Antibodies Business Overview
  7.8.3 Atlas Antibodies STAB2 Antibody (Stabilin-2 Precursor) Major Product Offerings
  7.8.4 Atlas Antibodies STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global Market (2017-2022)
  7.8.5 Atlas Antibodies Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. STAB2 Antibody (Stabilin-2 Precursor) Market Opportunities & Trends in Global Market
Table 2. STAB2 Antibody (Stabilin-2 Precursor) Market Drivers in Global Market
Table 3. STAB2 Antibody (Stabilin-2 Precursor) Market Restraints in Global Market
Table 4. Key Players of STAB2 Antibody (Stabilin-2 Precursor) in Global Market
Table 5. Top STAB2 Antibody (Stabilin-2 Precursor) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global STAB2 Antibody (Stabilin-2 Precursor) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global STAB2 Antibody (Stabilin-2 Precursor) Revenue Share by Companies, 2017-2022
Table 8. Global Companies STAB2 Antibody (Stabilin-2 Precursor) Product Type
Table 9. List of Global Tier 1 STAB2 Antibody (Stabilin-2 Precursor) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 STAB2 Antibody (Stabilin-2 Precursor) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - STAB2 Antibody (Stabilin-2 Precursor) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific STAB2 Antibody (Stabilin-2 Precursor) Product Offerings
Table 32. Thermo Fisher Scientific STAB2 Antibody (Stabilin-2 Precursor) Revenue (US$, Mn), (2017-2022)
Table 33. Merck (Sigma-Aldrich) Corporate Summary
Table 34. Merck (Sigma-Aldrich) STAB2 Antibody (Stabilin-2 Precursor) Product Offerings
Table 35. Merck (Sigma-Aldrich) STAB2 Antibody (Stabilin-2 Precursor) Revenue (US$, Mn), (2017-2022)
Table 36. Abcam Corporate Summary
Table 37. Abcam STAB2 Antibody (Stabilin-2 Precursor) Product Offerings
Table 38. Abcam STAB2 Antibody (Stabilin-2 Precursor) Revenue (US$, Mn), (2017-2022)
Table 39. R&D Systems Corporate Summary
Table 40. R&D Systems STAB2 Antibody (Stabilin-2 Precursor) Product Offerings
Table 41. R&D Systems STAB2 Antibody (Stabilin-2 Precursor) Revenue (US$, Mn), (2017-2022)
Table 42. Novus Biologicals Corporate Summary
Table 43. Novus Biologicals STAB2 Antibody (Stabilin-2 Precursor) Product Offerings
Table 44. Novus Biologicals STAB2 Antibody (Stabilin-2 Precursor) Revenue (US$, Mn), (2017-2022)
Table 45. Bioss Antibodies Corporate Summary
Table 46. Bioss Antibodies STAB2 Antibody (Stabilin-2 Precursor) Product Offerings
Table 47. Bioss Antibodies STAB2 Antibody (Stabilin-2 Precursor) Revenue (US$, Mn), (2017-2022)
Table 48. Boster Bio Corporate Summary
Table 49. Boster Bio STAB2 Antibody (Stabilin-2 Precursor) Product Offerings
Table 50. Boster Bio STAB2 Antibody (Stabilin-2 Precursor) Revenue (US$, Mn), (2017-2022)
Table 51. Atlas Antibodies Corporate Summary
Table 52. Atlas Antibodies STAB2 Antibody (Stabilin-2 Precursor) Product Offerings
Table 53. Atlas Antibodies STAB2 Antibody (Stabilin-2 Precursor) Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. STAB2 Antibody (Stabilin-2 Precursor) Segment by Type in 2021
Figure 2. STAB2 Antibody (Stabilin-2 Precursor) Segment by Application in 2021
Figure 3. Global STAB2 Antibody (Stabilin-2 Precursor) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global STAB2 Antibody (Stabilin-2 Precursor) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global STAB2 Antibody (Stabilin-2 Precursor) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by STAB2 Antibody (Stabilin-2 Precursor) Revenue in 2021
Figure 8. By Type - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue Market Share, 2017-2028
Figure 9. By Application - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue Market Share, 2017-2028
Figure 10. By Region - Global STAB2 Antibody (Stabilin-2 Precursor) Revenue Market Share, 2017-2028
Figure 11. By Country - North America STAB2 Antibody (Stabilin-2 Precursor) Revenue Market Share, 2017-2028
Figure 12. US STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe STAB2 Antibody (Stabilin-2 Precursor) Revenue Market Share, 2017-2028
Figure 16. Germany STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 17. France STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia STAB2 Antibody (Stabilin-2 Precursor) Revenue Market Share, 2017-2028
Figure 24. China STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 28. India STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America STAB2 Antibody (Stabilin-2 Precursor) Revenue Market Share, 2017-2028
Figure 30. Brazil STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa STAB2 Antibody (Stabilin-2 Precursor) Revenue Market Share, 2017-2028
Figure 33. Turkey STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE STAB2 Antibody (Stabilin-2 Precursor) Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific STAB2 Antibody (Stabilin-2 Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck (Sigma-Aldrich) STAB2 Antibody (Stabilin-2 Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abcam STAB2 Antibody (Stabilin-2 Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. R&D Systems STAB2 Antibody (Stabilin-2 Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novus Biologicals STAB2 Antibody (Stabilin-2 Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bioss Antibodies STAB2 Antibody (Stabilin-2 Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Boster Bio STAB2 Antibody (Stabilin-2 Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Atlas Antibodies STAB2 Antibody (Stabilin-2 Precursor) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)